Definitive Healthcare Corp. DH
We take great care to ensure that the data presented and summarized in this overview for Definitive Healthcare Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DH
View all-
Advent International Corp Boston, MA62.5MShares$348 Million8.87% of portfolio
-
Conestoga Capital Advisors, LLC5.6MShares$31.2 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$25.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$22.1 Million0.0% of portfolio
-
Brown Advisory Inc3.96MShares$22 Million0.04% of portfolio
-
Bamco Inc New York, NY3.49MShares$19.4 Million0.08% of portfolio
-
Massachusetts Financial Services CO Boston, MA3.45MShares$19.2 Million0.01% of portfolio
-
Spectrum Equity Management, Inc. San Francisco, CA2.51MShares$14 Million99.77% of portfolio
-
Fred Alger Management, LLC New York, NY2.22MShares$12.3 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.98MShares$11.1 Million0.0% of portfolio
Latest Institutional Activity in DH
Top Purchases
Top Sells
About DH
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Insider Transactions at DH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Kevin Coop Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,170,047
+50.0%
|
-
|
|
Jun 14
2024
|
Kate Marie Shamsuddin CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,044
-0.32%
|
$5,220
$5.62 P/Share
|
|
Jun 14
2024
|
Richard Douglas Booth CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.19%
|
$4,965
$5.62 P/Share
|
|
Jun 14
2024
|
Jason Ronald Krantz INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,003
-0.45%
|
$20,015
$5.62 P/Share
|
|
May 22
2024
|
Jill Larsen |
BUY
Grant, award, or other acquisition
|
Direct |
26,759
+31.26%
|
-
|
|
May 22
2024
|
Scott G Stephenson |
BUY
Grant, award, or other acquisition
|
Direct |
26,759
+28.18%
|
-
|
|
May 22
2024
|
Sastry Chilukuri |
BUY
Grant, award, or other acquisition
|
Direct |
26,759
+27.41%
|
-
|
|
May 22
2024
|
Samuel A Hamood |
BUY
Grant, award, or other acquisition
|
Direct |
26,759
+31.26%
|
-
|
|
May 22
2024
|
Kathleen A Winters |
BUY
Grant, award, or other acquisition
|
Direct |
26,759
+29.52%
|
-
|
|
May 03
2024
|
Jonathan Maack PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
10,021
-1.41%
|
$70,147
$7.03 P/Share
|
|
May 01
2024
|
Jason Ronald Krantz INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,658
-0.85%
|
$45,948
$6.97 P/Share
|
|
May 01
2024
|
Kate Marie Shamsuddin CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,506
-0.77%
|
$15,036
$6.97 P/Share
|
|
May 01
2024
|
Richard Douglas Booth CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,620
-0.71%
|
$21,720
$6.97 P/Share
|
|
May 01
2024
|
William Moschella Chief Product & Tech Officer |
BUY
Grant, award, or other acquisition
|
Direct |
297,686
+37.46%
|
-
|
|
Mar 14
2024
|
Jason Ronald Krantz INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,808
-0.31%
|
$22,464
$8.09 P/Share
|
|
Mar 14
2024
|
Kate Marie Shamsuddin CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,044
-0.32%
|
$8,352
$8.09 P/Share
|
|
Mar 14
2024
|
Richard Douglas Booth CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.19%
|
$7,944
$8.09 P/Share
|
|
Feb 16
2024
|
Jason Ronald Krantz INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,419
-0.59%
|
$48,771
$9.99 P/Share
|
|
Feb 14
2024
|
Jason Ronald Krantz INTERIM CEO |
BUY
Grant, award, or other acquisition
|
Direct |
417,752
+31.44%
|
-
|
|
Feb 14
2024
|
Richard Douglas Booth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
232,911
+31.17%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 3.25M shares |
|---|---|
| Conversion of derivative security | 2.9M shares |
| Other acquisition or disposition | 103K shares |
| Payment of exercise price or tax liability | 247K shares |
|---|---|
| Other acquisition or disposition | 6.09M shares |
| Open market or private sale | 6.66K shares |